NEWS: Learn more about the Biologics License Application (BLA) we submitted to the @US_FDA for an investigational, BCMA-directed T-cell engager treatment in relapsed/refractory #MultipleMyeloma: abbv.ie/oa17
00:00
AbbVie
@abbvie
Official global handle sharing the latest news about our company, science & people. Review our guidelines: abbv.ie/social-media
